Lv5
900 积分 2024-05-28 加入
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE)
1天前
已关闭
Discovery of Diaryl Piperidone-Sulfonamide as a Novel Dual-Target Inhibitor of STAT3/CAIX Inducing Ferroptosis in Triple-Negative Breast Cancer Cells
2天前
已完结
Regulating the Tumor Microbiome through Near-Infrared-III Light-Excited Photosynthesis
2个月前
已完结
Pseudovirus for immunotherapy
2个月前
已完结
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity
2个月前
已完结
Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
2个月前
已完结
针对VEGF受体激活的抗体-偶联药物
2个月前
已关闭
Dark Clouds Looming Over Regenerative Medicine in Japan
2个月前
已完结
Protein arginine methyltransferase 7 modulators in disease therapy: Current progress and emerged opportunity
2个月前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
2个月前
已完结
皖公网安备34019202002308
